AZD5305

Other Medications

EU Experimental ES Not available 2 Clinical Trials

Description

AZD5305 is an experimental drug currently being studied by AstraZeneca. It is being investigated as a potential treatment for advanced solid cancers, including colorectal cancer, although it is not yet approved for this use. Clinical trials are exploring AZD5305 both by itself (as monotherapy) and in combination with other cancer drugs. These trials are in the early phases (Phase 1), meaning they are primarily focused on determining the right dose and assessing safety in patients with advanced cancers. The goal is to see if AZD5305 can shrink tumors or slow their growth in these patients. It is taken orally.

Mechanism of Action

AZD5305 is being studied in clinical trials. The specific way it works (its mechanism of action) is still under investigation. It is being evaluated for its potential to target processes involved in cancer growth and survival.

Side Effects

Because AZD5305 is still in early-phase clinical trials (Phase 1) The full range of potential side effects is still being evaluated. Information about side effects from these early trials is not yet widely available. As more data becomes available from ongoing studies A clearer picture of the side effect profile will emerge.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT04644068 Phase 1
Active, not recruiting
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
United States, Australia, Canada, China, Czechia, Hungary, Italy, Japan, Poland,
NCT02264678 Phase 1
Active, not recruiting
Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents
United States, France, South Korea, United Kingdom

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials2
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
779 trials
Leucovorin
Other Medications
639 trials
Paclitaxel
Other Medications
54 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials
Trifluridine
Other Medications
47 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.